1. Review the eveidence supporting the link between thegut microbiota and its effect on anti-cancer treatment.
2. Highlight novel strategies to modulate the gut microbiome to optimize efficacy of PD-1 based immunotherapy
3. Discuss potential clinical studies to assess safety and feasibility of gut mirobiome interventions
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation